Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influvac 2010/2011 Immunogenicity and Safety
NCT01146015Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2010
- Primary completion
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 3 trial of inactivated influenza vaccine (surface antigen) in influenza, sponsored by Abbott Laboratories. Started Jun 2010; status: completed.
02
Drugs
inactivated influenza vaccine (surface antigen)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01146015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146015.